T. Rowe Price Group heads into its July 30 earnings print with short sellers adding positions at the fastest weekly pace in months — yet the broader lending picture tells a more nuanced story.
Short interest is the headline tension this week. Bears have added meaningfully, with SI climbing nearly 8% in a single week to 12.9% of the free float — around 28 million shares short. That puts the position back near the upper end of its recent range, having drifted between 24.7 million and 28.2 million shares over the past six weeks. The build happened fast: from roughly 26 million shares on July 7 to a peak of 28.2 million by July 13, before easing slightly. Days to cover sits close to 10, meaning unwinding the position is not a quick trade.
The lending market, however, is not backing up the bears. Availability is comfortable at around 305% — meaning there are roughly three shares available to borrow for every two already lent out — and the borrow cost has collapsed. Cost to borrow is running below 0.5%, down from a brief spike above 1.7% in mid-June. That spike has fully unwound, and lenders are pricing this as a routine borrow. With the ORTEX short score sitting at 71.7, elevated but not at an extreme, and the days-to-cover rank and utilization rank both in the lowest quartile of the universe, the positioning looks more like a considered bearish bet than a crowded squeeze setup. Options are similarly relaxed: the put/call ratio of 0.83 sits less than half a standard deviation above its 20-day average, with no unusual demand for downside protection.
Analysts are also chasing the stock higher without yet turning bullish. Barclays raised its target to $108 from $89 this week while holding its Underweight rating — a meaningful concession to price action but still below the current $116 close. Evercore ISI and Keefe, Bruyette & Woods both lifted targets last week, to $121 and $120 respectively, though neither moved their neutral-equivalent ratings. Morgan Stanley raised to $109 in late June. The pattern is consistent: the Street is revising higher but staying cautious, and the mean target of $110 sits nearly 5% below where the stock is trading. The stock rose 2.1% on July 14, yet is still down 3.4% on the week, caught between a sharp one-day bounce and broader softness. The P/E multiple at roughly 11x and EV/EBITDA near 7x suggest value-screen buyers have a case, though the earnings momentum factor score ranks in just the 12th percentile on the 30-day view — a signal that estimate revisions are not yet running in bulls' favour.
The bull case rests on AUM resilience: $1.77 trillion under management, ETF net inflows of $2.5 billion in Q2, and a strong dividend that scores in the 93rd percentile against the market. The bear case points to below-consensus fee rates, margin pressure, and the structural headwinds facing active managers. Closest peer IVZ gained nearly 5% on the week, while BX added 3% — both outperforming TROW, which underscores that the lag is more stock-specific than sector-wide.
The July 30 print is the next hard catalyst. Recent earnings reactions have been modest — a 0.75% down-day and 0.2% up-day in recent quarters, with a 2.9% jump on the most recent print — suggesting the stock does not tend to make dramatic moves on results. With shorts rebuilding, the Street still below market, and the borrow cost low enough to sustain the position cheaply, the key variable on July 30 is whether Q2 AUM flows and fee-rate trends come in ahead of the cautious consensus or confirm the bears' margin concerns.
See the live data behind this article on ORTEX.
Open TROW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
